Swen Engelmann
About Swen Engelmann
Swen Engelmann is a Pharmareferent at Bristol Myers Squibb, specializing in cardiovascular pharmaceuticals, with over six years of experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Swen Engelmann serves as a Pharmareferent at Bristol Myers Squibb. He began his tenure at the company in January 2017. His responsibilities include promoting cardiovascular pharmaceuticals. Swen Engelmann leverages his extensive experience in the pharmaceutical industry to contribute to the company's mission.
Previous Experience at Universitätsklinikum Essen
From 2015 to 2016, Swen Engelmann worked as a Postdoktoraler Mitarbeiter at Universitätsklinikum Essen Anstalt des öffentl. Rechts in Essen. During his one-year tenure, he was involved in various postdoctoral research activities, focusing on medical and clinical research within the hospital setting.
PhD from Otto-von-Guericke University Magdeburg
Swen Engelmann completed his PhD at Otto-von-Guericke University Magdeburg, where he worked from 2005 to 2014. His nine-year stint at the university was dedicated to deepening his knowledge and research skills in his field of study. This academic experience laid the foundation for his subsequent roles in the pharmaceutical and medical research sectors.
Specialization in Cardiovascular Pharmaceuticals
Swen Engelmann specializes in cardiovascular pharmaceuticals. This specialization has guided his career, particularly in his current role at Bristol Myers Squibb. His expertise in this area is backed by years of academic research and industry experience, allowing him to effectively promote and support cardiovascular treatments.
Based in Haltern am See, Nordrhein-Westfalen
Swen Engelmann is based in Haltern am See, Nordrhein-Westfalen, Germany. His location puts him in proximity to key pharmaceutical and medical research hubs in the region. This geographic base supports his role at Bristol Myers Squibb and connects him with the wider scientific and medical community.